Ho K. Lee
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease.
Journal: Journal of medicinal chemistry
Published: December 27, 2022
Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice.
Journal: International journal of molecular sciences
Published: March 24, 2022
Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin.
Journal: Acta pharmacologica Sinica
Published: November 22, 2021
Isorhamnetin Ameliorates Dry Eye Disease via CFTR Activation in Mice.
Journal: International journal of molecular sciences
Published: March 02, 2021
Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells.
Journal: PloS one
Published: January 04, 2017
Ani9, A Novel Potent Small-Molecule ANO1 Inhibitor with Negligible Effect on ANO2.
Journal: PloS one
Published: February 24, 2016
Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines.
Journal: PloS one
Published: June 09, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026